Clinical trials: Submassive Pulmonary Embolism
Pulmonary Embolism
Clot Dissolving Treatment for Blood Clots in the Lungs
The purpose of this study is to determine if tenecteplase plus enoxaparin is safe and effective in the treatment of patients with severe submassive pulmonary embolism.
- Trial name
- NCT00680628
- Testing
- Tenecteplase + Enoxaparin, 0.9% Saline + Enoxaparin
- Where
- 7 sites in United States
- Volunteers
- 83 people
- Sponsor
- Wake Forest University Health Sciences